Intuitive Surgical (NASDAQ:ISRG) Shares Down 0.4% on Insider Selling

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s share price dropped 0.4% during trading on Tuesday after an insider sold shares in the company. The company traded as low as $563.85 and last traded at $571.10. Approximately 572,352 shares traded hands during trading, a decline of 70% from the average daily volume of 1,933,652 shares. The stock had previously closed at $573.48.

Specifically, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Analysts Set New Price Targets

A number of analysts have weighed in on ISRG shares. Mizuho increased their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, UBS Group lifted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Up 1.3 %

The firm has a 50 day simple moving average of $549.32 and a 200 day simple moving average of $507.50. The firm has a market capitalization of $206.65 billion, a PE ratio of 93.28, a P/E/G ratio of 5.19 and a beta of 1.39.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $38,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.